Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
56.19 USD | -0.20% | +0.29% | +25.06% |
Apr. 12 | Zacks Investment Research Downgrades Catalent to Underperform From Neutral, Price Target is $48 | MT |
Apr. 08 | Sector Update: Health Care Stocks Decline Late Afternoon | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+25.06% | 10.19B | |
+33.40% | 664B | |
+29.29% | 567B | |
-7.23% | 354B | |
+19.13% | 330B | |
+4.62% | 286B | |
+13.79% | 234B | |
+4.93% | 199B | |
-9.78% | 196B | |
-4.75% | 148B |
- Stock Market
- Equities
- CTLT Stock
- News Catalent, Inc.
- Zacks Investment Research Downgrades Catalent to Underperform From Neutral, Price Target is $48